Since the start of the pandemic, UnitedHealth Group has continued to adapt to better serve at-risk patients. Here’s how Sponsored by Teradata
UHG currently uses Vivify to serve 10,000 high-risk patients, and the program took on new significance during COVID-19, when at-home monitoring became critical for older and immuno-compromised patients who couldn’t risk infection by visiting the hospital.
UHG’s solution was to begin mailing her prescriptions on a routine schedule. “One of the things that we find in medicine is that many times, it's not the knowledge of what to do but the interference of social determinants such as fear or lack of transportation,” says Dr. Migliori. “So half of what we do is medical, and half is social.”In medicine, uncertainty is dangerous. Hospitals need to have an idea of how many ICU beds, ventilators and attending medics they’ll need at any given moment.
By building a new tool specifically for COVID-19, UHG was able to run surge predictions for the roughly 700 health systems it serves. It draws on county-level infection and mortality reports, hospital admissions data and census demographic information to help hospitals brace for impact. UHG determined, for instance, that 17% of people admitted for COVID-19 would end up on ventilatory support, in general.
Even before COVID-19 hit, data analytics powered many of UHG’s most exciting initiatives. Through the company’s carefully managed Unified Data Warehouse, different divisions have been sharing information that empowers quick and decisive decision making. Now, as the healthcare industry considers how to prepare for a second wave of the coronavirus and recover from its lasting impact, UHG’s data repository and its commitment to building on it have been key.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
New Zealand economy doing better than expected, finance minister saysNew Zealand's economy is currently doing better than predicted due to the country's early economic and health response to the COVID-19 pandemic, the finance minister said on Monday.
続きを読む »
Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stageAt least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a more durable form...
続きを読む »
Essential Workers Are on Strike Today to Support Black LivesMembers of various unions and supporters spanning the hospitality, janitorial, elder care, and restaurant industries are expected to walk off the job today.
続きを読む »
Oxford Coronavirus Vaccine 'Safe' And Showing 'Promising Results'A clinical trial of the vaccine against COVID-19 found it induces an immune reaction.
続きを読む »